Kenya is aiming to become a regional pharmaceutical production hub with 13 new manufacturers establishing facilities to boost local medicine supply and reduce import dependence.

• These investments are expected to expand domestic supply and create skilled employment, supporting government efforts to produce at least 50% of essential health products locally.
• Key organizations involved include the Pharmacy and Poisons Board (PPB) and the 13 new manufacturers such as Med Aditus and Kenya Biovax Institute.
• The PPB is providing regulatory support and guidance to ensure compliance with national and international standards, aiming to enhance Kenya's capacity to manufacture pharmaceutical ingredients and achieve WHO Global Benchmarking Tool Maturity Level 3 status.